亚太微阵列分析市场:按产品、类型、应用、最终用户、国家 - 分析和预测(2023-2033)
市场调查报告书
商品编码
1599907

亚太微阵列分析市场:按产品、类型、应用、最终用户、国家 - 分析和预测(2023-2033)

Asia-Pacific Microarray Analysis Market: Focus on Product, Type, Application, End User, and Country Level Analysis - Analysis and Forecast, 2023-2033

出版日期: | 出版商: BIS Research | 英文 76 Pages | 商品交期: 1-5个工作天内

价格

2023年亚太地区微阵列分析市场规模达10.4亿美元。

预计到 2033 年,该市场将达到 22.8 亿美元,2023-2033 年预测期间复合年增长率为 8.16%。由于基因组学计划的增加、微阵列技术在药物筛检中的使用不断增加以及在癌症检测中的作用日益增强,亚太地区的微阵列分析市场正在不断增长。该市场涵盖广泛的消耗品、设备、软体和服务,正在推动整个地区基因组学和个人化医疗的进步。

主要市场统计数据
预测期 2023-2033
2023年评估 10.4亿美元
2033 年预测 22.8亿美元
复合年增长率 8.16%

由于生物技术、基因组学和个体化医疗的发展,亚太地区微阵列分析市场正在迅速扩大。药物发现、疾病诊断和研究越来越多地利用微阵列技术,该技术可以同时检查数千个基因。癌症发病率的上升和对精准医疗的日益重视推动了疾病筛检和生物标记识别中对基于微阵列的解决方案的需求。

由于对基因组研究和医疗基础设施的大量投资,中国、日本和印度等国家正在发挥关键作用。该市场透过广泛的产品和服务来支援临床实践和研究,包括耗材、设备、软体和资料分析工具。此外,生物技术产业的成长以及私人公司和学术机构之间的合作也进一步推动了市场的成长。随着亚太地区继续投资医疗技术,微阵列分析市场预计在未来几年将大幅扩张。

该报告研究了亚太地区微阵列分析市场,并提供了市场概况,包括按产品、类型、应用、最终用户、国家和参与市场的公司概况分類的趋势。

目录

执行摘要

第一章 市场

  • 趋势:当前和未来的影响评估
  • 生态系概观:微阵列分析市场
  • 研究发展回顾
  • 监管状况
  • 全球重大事件的影响分析 - COVID-19
  • 价格分析
  • 市场动态概览

第二章 区域

  • 区域概况
  • 促进因素和抑制因素
  • 亚太地区

第三章市场-竞争基准化分析与公司概况

  • 未来展望
  • 竞争力评估

第四章调查方法

Product Code: BHP2411SS

Introduction to Asia-Pacific Microarray Analysis Market

The Asia-Pacific microarray analysis market was valued at $1.04 billion in 2023 and is expected to reach $2.28 billion by 2033, growing at a CAGR of 8.16% during the forecast period 2023-2033. The APAC microarray analysis market is experiencing growth, fueled by the rising number of genomics initiatives, the expanding use of microarray technology in drug screening, and its growing role in cancer detection. The market covers a broad spectrum of consumables, instruments, software, and services, driving progress in genomics and personalized medicine across the region.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$1.04 Billion
2033 Forecast$2.28 Billion
CAGR8.16%

The market for APAC microarray analysis is expanding quickly because to developments in biotechnology, genomics, and customized medicine. Drug discovery, disease diagnostics, and research are just a few of the fields that are using microarray technology more and more since it allows for the simultaneous examination of thousands of genes. The need for microarray-based solutions in disease screening and biomarker identification is being driven by the rising incidence of cancer and the increased emphasis on precision medicine.

Thanks to large investments in genomics research and healthcare infrastructure, nations like China, Japan, and India are becoming important actors. The market supports both clinical and research applications with a broad range of goods and services, such as consumables, instruments, software, and data analytics tools. Furthermore, the growing biotechnology industry and partnerships between private businesses and university institutions are further driving market growth. As the APAC region continues to invest in medical technologies, the microarray analysis market is expected to witness significant expansion in the coming years.

Market Segmentation:

Segmentation 1: by Product Type

  • Instruments
  • Consumables
  • Software and Services

Segmentation 2: by Type

  • DNA Microarray
  • Protein Microarray
  • Other Microarray

Segmentation 3: by Application

  • Clinical Diagnostics
  • Drug Discovery and Translational Research
  • Others

Segmentation 4: by End User

  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Others

Segmentation 5: by Country

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The Asia-Pacific microarray analysis market (by product) has been segmented into detailed segments, including different types of consumables, such as arrays, kits and reagents, and accessories as well as instruments, and software and services.

Growth/Marketing Strategy: A strategic growth and marketing approach for the microarray analysis market would involve positioning the company as a leader in innovative solutions that address the evolving needs of researchers, clinicians, and pharmaceutical partners. This would entail leveraging technological advancements to develop cutting-edge products with enhanced sensitivity, specificity, and scalability, while also investing in comprehensive customer support, training programs, and collaborative partnerships to foster customer loyalty and drive market penetration.

Competitive Strategy: Key players in the APAC microarray analysis market have been focusing on innovation, differentiation, and strategic collaborations to gain a competitive edge. By investing in research and development, companies can develop novel detection methods, improve assay sensitivity, and expand application areas. Differentiation through the development of proprietary technologies, customizable solutions, and value-added services can help companies stand out in a crowded market. to strengthen market positions, acquire new technologies, and broaden product portfolios.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Key Trends
      • 1.1.1.1 Technological Advancements in Microarray Analysis
      • 1.1.1.2 Developing Focus on Automation and Artificial Intelligence Integration in Microarray Analysis
  • 1.2 Ecosystem Overview: Microarray Analysis Market
    • 1.2.1 Value Addition Across the Process
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Company)
  • 1.4 Regulatory Landscape
  • 1.5 Impact Analysis for Key Global Events - COVID-19
  • 1.6 Pricing Analysis
  • 1.7 Market Dynamics Overview
    • 1.7.1 Market Drivers
      • 1.7.1.1 Rising Numbers of Genomics Projects Fuelling the Growth of Microarray Analysis Market
      • 1.7.1.2 Use of Microarray Technology in Drug Discovery
      • 1.7.1.3 Increasing Adoption of Microarray Technology in Cancer Screening
    • 1.7.2 Market Restraints
      • 1.7.2.1 Competition from Alternative Technologies such as NGS
      • 1.7.2.2 Challenges in Complex Data Analysis due to Lack of Skilled Professionals
    • 1.7.3 Market Opportunities
      • 1.7.3.1 Novel Biomarker Discovery with the Use of Microarray Technology
      • 1.7.3.2 Utilization of Predictive Genomics for the Development of Personalized Medicines

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Asia-Pacific
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 China
    • 2.3.5 Japan
    • 2.3.6 India
    • 2.3.7 Australia
    • 2.3.8 South Korea
    • 2.3.9 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Next Frontiers
  • 3.2 Competitive Assessment

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-Pacific Microarray Analysis Market, $Million, 2023, 2026, and 2033
  • Figure 2: Microarray Analysis Market (by Region), $Million, 2022, 2026, and 2033
  • Figure 3: Asia-Pacific Microarray Analysis Market (by Application), $Million, 2022, 2026, and 2033
  • Figure 4: Asia-Pacific Microarray Analysis Market (by Type), $Million, 2022, 2026, and 2033
  • Figure 5: Asia-Pacific Microarray Analysis Market (by Product), $Million, 2022, 2026, and 2033
  • Figure 6: Asia-Pacific Microarray Analysis Market (by End User), $Million, 2022, 2026, and 2033
  • Figure 7: Key Industrial Developments in Microarray Analysis Market, 2023
  • Figure 8: Opportunities in Genetic Research through AI and Automation
  • Figure 9: Ecosystem Overview of Microarray Analysis Market and Operational Challenges
  • Figure 10: Microarray Analysis Market, Patent Analysis (by Country), January 2020-December 2023
  • Figure 11: Microarray Analysis Market, Patent Analysis (by Year), January 2020-December 2023
  • Figure 12: Examples of the Key Initiative Related to Genomics
  • Figure 13: Applications of Microarray Analysis Technology in Drug Discovery
  • Figure 14: Microarray vs. RNA Sequencing, NGS, and PCR
  • Figure 15: Pitfalls in Data Analysis due to Lack of Skilled Professionals
  • Figure 16: Key Initiatives Focused on Pharmacogenomics to Improve the Landscape of Precision Medicine
  • Figure 17: Precision Medicine vs. Other Medicine
  • Figure 18: China Microarray Analysis Market, $Million, 2022-2033
  • Figure 19: Japan Microarray Analysis Market, $Million, 2022-2033
  • Figure 20: Australia Microarray Analysis Market, $Million, 2022-2033
  • Figure 21: South Korea Microarray Analysis Market, $Million, 2022-2033
  • Figure 22: Rest-of-Asia-Pacific Microarray Analysis Market, $Million, 2022-2033
  • Figure 23: Strategic Initiatives, 2021-2024
  • Figure 24: Share of Strategic Initiatives, 2021-2024
  • Figure 25: Data Triangulation
  • Figure 26: Top-Down and Bottom-Up Approach
  • Figure 27: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Microarray Analysis Market, Opportunities
  • Table 3: Key Companies and Technological Advancements, 2022-2023
  • Table 4: Pricing Analysis of Microarray Analysis Products (Instruments and Consumables)
  • Table 5: Impact Analysis of Market Navigating Factors, 2022-2033
  • Table 6: Examples of Arrays Used in Cancer Screening
  • Table 7: Microarray Analysis Market (by Region), $Million, 2022-2033
  • Table 8: Asia-Pacific Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 9: Asia-Pacific Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 10: Asia-Pacific Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 11: Asia-Pacific Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 12: China Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 13: China Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 14: China Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 15: China Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 16: Japan Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 17: Japan Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 18: Japan Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 19: Japan Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 20: India Microarray Analysis Market, $Million, 2022-2033
  • Table 21: India Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 22: India Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 23: India Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 24: India Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 25: Australia Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 26: Australia Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 27: Australia Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 28: Australia Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 29: South Korea Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 30: South Korea Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 31: South Korea Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 32: South Korea Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 33: Rest-of-Asia-Pacific Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 34: Rest-of-Asia-Pacific Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 35: Rest-of-Asia-Pacific Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 36: Rest-of-Asia-Pacific Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 37: Company Market Share, 2022